Alzheimers Res Ther. 2013 Jul 08;5:S5. doi: 10.1186/alzrt201. Epub 2013 Jul 08.
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.
Alzheimer's research & therapy
Nathan Herrmann, Krista L Lanctôt, David B Hogan
PMID: 24565367
PMCID: PMC3980908 DOI: 10.1186/alzrt201
Abstract
BACKGROUND: While there have been no new medications approved for the treatment of Alzheimer's disease (AD) or other dementias in Canada since 2004, the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD) reviewed and updated the clinical practice guidelines on the pharmacological management of dementia that were published previously.
METHODS: This review focused on the literature for the pharmacological treatment of dementia based on studies published since the third CCCDTD in 2006. A literature search of English-language medical databases was preformed for studies pertaining to the pharmacological treatment of AD and other dementias that examined the management of cognitive and functional impairment, as well as neuropsychiatric symptoms. All previous recommendations were reviewed, and only those that required updating based on new published studies were revised. Several new recommendations were also added. Recommendations were rated for quality of evidence and were approved by consensus.
RESULTS: There were 15 revised or new recommendations approved by consensus. The revised recommendations included acknowledging that cholinesterase inhibitors (ChEIs) possess a class effect and any of the agents can be used for AD across the spectrum of severity and with co-existing cerebrovascular disease. There was insufficient evidence to recommend for or against the use of ChEIs in combination with memantine for the primary indication of treating neuropsychiatric symptoms, or for the treatment of vascular dementia. Recommendations for the discontinuation of cognitive enhancers were revised and clarified, as well as the risks associated with discontinuing these drugs. ChEIs were recommended as a treatment option for dementia with Parkinson's disease. Risks associated with use of antipsychotics for neuropsychiatric symptoms were strengthened, and guidelines regarding the use of antidepressants for affective disturbances in dementia were weakened, and are now considered an option but not a firm recommendation. Valproate was recommended not to be used, and there was insufficient evidence to recommend for or against the use of selective serotonin reuptake inhibitors or trazodone for the treatment of agitation and aggression.
CONCLUSION: In spite of the lack of new therapeutic agents for the treatment of dementia, recent studies have helped to clarify and strengthen recommendations to optimize the pharmacological management of these illnesses.
References
- Neurology. 2001 Aug 28;57(4):613-20 - PubMed
- J Clin Psychiatry. 2008 Dec;69(12):1981-2 - PubMed
- Am J Geriatr Psychiatry. 2012 Sep;20(9):789-97 - PubMed
- Am J Psychiatry. 2009 May;166(5):583-90 - PubMed
- Drugs. 2011 Oct 22;71(15):2031-65 - PubMed
- Am J Psychiatry. 2012 Jan;169(1):71-9 - PubMed
- Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):211-7 - PubMed
- CMAJ. 2008 Dec 2;179(12):1279-87 - PubMed
- Neurology. 2007 Jul 31;69(5):448-58 - PubMed
- Lancet Neurol. 2009 Feb;8(2):151-7 - PubMed
- Eur J Neurol. 2010 Oct;17(10):1236-48 - PubMed
- PLoS Med. 2009 Sep;6(9):e1000157 - PubMed
- Arch Intern Med. 2005 Sep 12;165(16):1882-8 - PubMed
- J Clin Psychopharmacol. 2005 Oct;25(5):463-7 - PubMed
- Drugs Aging. 2010 Sep 1;27(9):715-28 - PubMed
- Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed
- Neurology. 2006 Apr 11;66(7):996-1002 - PubMed
- N Engl J Med. 2007 Oct 4;357(14):1382-92 - PubMed
- Ann Neurol. 2007 Oct;62(4):406-13 - PubMed
- Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504 - PubMed
- Arch Gen Psychiatry. 2011 Feb;68(2):190-7 - PubMed
- Lancet. 2004 Jun 26;363(9427):2105-15 - PubMed
- Ann Pharmacother. 2004 Nov;38(11):1967-8 - PubMed
- N Z Med J. 2011 Jun 10;124(1336):39-50 - PubMed
- J Geriatr Psychiatry Neurol. 2005 Dec;18(4):224-7 - PubMed
- Alzheimers Dement. 2007 Oct;3(4):385-97 - PubMed
- Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43 - PubMed
- Int J Geriatr Psychiatry. 2008 Jul;23(7):754-9 - PubMed
- Alzheimers Dement. 2007 Oct;3(4):355-84 - PubMed
- Stroke. 2003 Oct;34(10):2323-30 - PubMed
- N Engl J Med. 2004 Dec 9;351(24):2509-18 - PubMed
- Psychopharmacology (Berl). 2004 Apr;172(4):400-8 - PubMed
- Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):185-92 - PubMed
- JAMA. 2004 Jan 21;291(3):317-24 - PubMed
- Int J Geriatr Psychiatry. 2003 Apr;18(4):282-4 - PubMed
- Arch Intern Med. 2009 May 11;169(9):867-73 - PubMed
- Dement Geriatr Cogn Disord. 2008;25(2):178-85 - PubMed
- Int J Geriatr Psychiatry. 2004 Jan;19(1):58-67 - PubMed
- Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746 - PubMed
- Arch Gen Psychiatry. 2011 Aug;68(8):853-61 - PubMed
- Int Psychogeriatr. 2011 May;23(4):539-45 - PubMed
- CMAJ. 2008 Nov 4;179(10):1019-26 - PubMed
- Int Psychogeriatr. 2011 Nov;23(9):1515-9 - PubMed
- Lancet. 2002 Apr 13;359(9314):1283-90 - PubMed
- Dement Geriatr Cogn Disord. 2004;17(4):355-9 - PubMed
- Drugs Aging. 2004;21(14):931-7 - PubMed
- Alzheimers Dement. 2007 Oct;3(4):398-403 - PubMed
- Neurology. 2007 Dec 11;69(24):2197-204 - PubMed
- J Alzheimers Dis. 2011;23(4):749-59 - PubMed
- Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):129-41 - PubMed
- Lancet Neurol. 2009 Jan;8(1):39-47 - PubMed
- Lancet Neurol. 2011 Feb;10(2):162-72 - PubMed
- CMAJ. 2011 Apr 19;183(7):E411-9 - PubMed
- BMJ. 2012 Feb 23;344:e977 - PubMed
- J Clin Psychiatry. 1997 May;58(5):212-6 - PubMed
- Int J Clin Pract. 2002 Jul-Aug;56(6):441-6 - PubMed
- Can J Neurol Sci. 2012 Nov;39(6 Suppl 5):S1-8 - PubMed
- Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):125-8 - PubMed
- World J Biol Psychiatry. 2011 Feb;12(1):2-32 - PubMed
- J Alzheimers Dis. 2011;26(2):211-20 - PubMed
- Curr Med Res Opin. 2009 Nov;25(11):2577-87 - PubMed
- Curr Alzheimer Res. 2008 Feb;5(1):83-9 - PubMed
- Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45 - PubMed
- Drugs Aging. 2003;20(10):777-89 - PubMed
- Neurology. 2003 Aug 26;61(4):479-86 - PubMed
- Int J Geriatr Psychiatry. 2002 Oct;17(10):968-73 - PubMed
- Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56 - PubMed
- Lancet. 2011 Jul 30;378(9789):403-11 - PubMed
- Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31 - PubMed
- Arch Neurol. 2001 Mar;58(3):427-33 - PubMed
- Am J Psychiatry. 2011 Aug;168(8):831-9 - PubMed
- Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210 - PubMed
- J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9 - PubMed
- Mov Disord. 2011 Oct;26 Suppl 3:S42-80 - PubMed
- Stroke. 2010 Jun;41(6):1213-21 - PubMed
- CMAJ. 2008 May 6;178(10):1273-85 - PubMed
- Dement Geriatr Cogn Disord. 2008;26(4):343-50 - PubMed
- BMJ. 2012 Mar 22;344:e1086 - PubMed
- Ann Neurol. 2009 Aug;66(2):200-8 - PubMed
- Can J Psychiatry. 2007 Oct;52(10):630-46 - PubMed
- Am J Psychiatry. 1982 Sep;139(9):1136-9 - PubMed
- JAMA. 2011 Sep 28;306(12):1359-69 - PubMed
- Can J Psychiatry. 2007 Apr;52(4):248-55 - PubMed
- BMJ. 2012 Mar 09;344:e1566 - PubMed
- Qual Saf Health Care. 2003 Feb;12(1):18-23 - PubMed
- Am J Geriatr Psychiatry. 2007 Nov;15(11):942-52 - PubMed
- Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):670-9 - PubMed
- Curr Med Res Opin. 2008 Sep;24(9):2561-74 - PubMed
- CMAJ. 2003 Sep 16;169(6):557-64 - PubMed
- Chest. 2008 Jun;133(6 Suppl):123S-131S - PubMed
- Lancet Neurol. 2004 Oct;3(10):622-6 - PubMed
- Neurology. 2011 Sep 27;77(13):1263-71 - PubMed
- Neurology. 2007 Jul 31;69(5):459-69 - PubMed
- J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):708-12 - PubMed
- Eur Neurol. 2003;49(1):13-9 - PubMed
- Eur J Neurol. 2000 Mar;7(2):159-69 - PubMed
- Lancet. 2005 Dec 17;366(9503):2112-7 - PubMed
- CMAJ. 2008 Jan 29;178(3):316-21 - PubMed
- Int J Clin Pract. 2010 Jan;64(2):188-93 - PubMed
- Am J Geriatr Psychiatry. 2008 Jul;16(7):537-50 - PubMed
- Br J Psychiatry. 1999 Jan;174:45-50 - PubMed
- Neurology. 2004 Jul 27;63(2):214-9 - PubMed
- Nat Rev Neurol. 2009 Dec;5(12):649-58 - PubMed
- Dement Geriatr Cogn Disord. 2008;25(5):399-407 - PubMed
- CMAJ. 2008 Feb 26;178(5):548-56 - PubMed
- N Engl J Med. 2012 Mar 8;366(10):893-903 - PubMed
- Drug Saf. 2003;26(9):643-59 - PubMed
- Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191 - PubMed
- Curr Med Res Opin. 2005 Aug;21(8):1317-27 - PubMed
- Lancet. 2006 Apr 1;367(9516):1057-1065 - PubMed
- Int Psychogeriatr. 2002 Dec;14(4):389-404 - PubMed
- Lancet. 2001 Jan 20;357(9251):169-75 - PubMed
- Arch Intern Med. 2009 Jul 27;169(14):1282-9 - PubMed
Publication Types